Table 3.
Quality assessment of the included studies using the Methodological Index for Non-Randomized Studies (MINORS) criteria
| Authors | Year | Journal | Evidence | Study design | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Total | % of max. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TSA/HA studies | ||||||||||||||||||
| Aibinder et al27 | 2019 | JSES | IV | Retrospective cohort comparison | 2 | 1 | 0 | 2 | 1 | 2 | 1 | 0 | 2 | 0 | 1 | 1 | 13 | 54% |
| Athwal et al42 | 2019 | JSES | IV | Prospective case series | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 2 | 13 | 81% | ||||
| Ballas et al6 | 2016 | Intern Orthop | IV | Retrospective case series | 2 | 2 | 0 | 2 | 1 | 2 | 2 | 0 | 11 | 69% | ||||
| Beck et al28 | 2018 | Intern Orthop | IV | Prospective case series | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 0 | 10 | 63% | ||||
| Bell and Coghlan55 | 2014 | IJSS | IV | Prospective case series | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 0 | 9 | 56% | ||||
| Bell et al25 | 2019 | JSES | III | Retrospective cohort comparison | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 1 | 1 | 2 | 16 | 67% |
| Berth and Pap9 | 2013 | JOT | II | Prospective randomized | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 2 | 1 | 16 | 67% |
| Brunner et al30 | 2012 | Ob Extrem | IV | Prospective case series | 2 | 1 | 2 | 1 | 0 | 1 | 0 | 0 | 7 | 44% | ||||
| Bülhoff et al31 | 2019 | AOTT | IV | Retrospective case series | 2 | 1 | 0 | 2 | 0 | 2 | 1 | 0 | 8 | 50% | ||||
| Churchill et al32 | 2016 | JBJS | IV | Prospective case series | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 2 | 14 | 88% | ||||
| Collin et al33 | 2017 | Intern Orthop | IV | Prospective case series | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 0 | 11 | 69% | ||||
| Gallacher et al34 | 2018 | JSES | IV | Retrospective case series | 1 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 8 | 50% | ||||
| Habermeyer et al35 | 2015 | JSES | IV | Prospective case series | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 0 | 11 | 69% | ||||
| Hawi et al36 | 2017 | JSES | IV | Prospective case series | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 0 | 11 | 69% | ||||
| Heuberer et al8 | 2018 | BMC Musc Dis | IV | Prospective case series | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 2 | 13 | 81% | ||||
| Huguet et al37 | 2010 | JSES | IV | Prospective case series | 2 | 1 | 2 | 2 | 0 | 2 | 1 | 0 | 10 | 63% | ||||
| Johansson et al49 | 2017 | BMC Musc Dis | IV | Retrospective cohort comparison | 2 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 1 | 2 | 1 | 2 | 14 | 58% |
| Jordan et al41 | 2019 | Musc Surg | IV | Retrospective cohort comparison | 2 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 1 | 1 | 0 | 2 | 13 | 54% |
| Krukenburg et al | 2018 | JSES | IV | Prospective case series | 2 | 2 | 2 | 2 | 0 | 1 | 1 | 2 | 12 | 75% | ||||
| Moursy et al40 | 2019 | BMC Musc Dis | IV | Prospective case series | 1 | 2 | 0 | 2 | 0 | 2 | 1 | 0 | 8 | 50% | ||||
| Razmjou et al23 | 2013 | JSES | III | Prospective controlled | 2 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 2 | 1 | 1 | 2 | 16 | 67% |
| Spranz et al26 | 2017 | BMC Musc Dis | III | Prospective controlled | 2 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 1 | 14 | 58% |
| Uschok et al22 | 2017 | JSES | II | Prospective randomized | 2 | 2 | 2 | 2 | 0 | 2 | 1 | 0 | 2 | 2 | 1 | 1 | 17 | 71% |
| RSA Studies | ||||||||||||||||||
| Atoun et al43 | 2014 | Intern Orthop | IV | Prospective case series | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 0 | 12 | 75% | ||||
| Ballas and Béguin44 | 2013 | JSES | IV | Prospective case series | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 0 | 11 | 69% | ||||
| Beck et al29 | 2019 | AOTS | IV | Prospective case series | 1 | 1 | 2 | 2 | 0 | 2 | 1 | 0 | 9 | 56% | ||||
| Kadum et al24 | 2014 | Intern Orthop | III | Prospective controlled | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 1 | 2 | 1 | 1 | 17 | 71% |
| Leonidou et al45 | 2020 | EJOST | IV | Prospective case series | 2 | 0 | 2 | 2 | 1 | 1 | 0 | 0 | 8 | 50% | ||||
| Levy et al46 | 2016 | JSES | IV | Prospective case series | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 0 | 13 | 81% | ||||
| Moroder et al47 | 2016 | Intern Orthop | IV | Retrospective cohort comparison | 2 | 2 | 0 | 2 | 2 | 1 | 1 | 0 | 2 | 1 | 2 | 1 | 16 | 67% |
| Teissier et al48 | 2015 | JSES | IV | Prospective case series | 0 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 8 | 50% | ||||
Notes. The criteria of MINORS with 0 points when not reported, 1 when reported but not adequate, and 2 when reported and adequate. Maximum score is 16 in non-comparative studies and 24 in comparative studies.
% of max., percentage of maximum score; JSES, Journal of Shoulder and Elbow Surgery; Intern Orthop, International Orthopedics(SICOT), IJSS, International Journal of Shoulder Surgery; JOT, Journal of Orthopaedics and Traumatology; Ob Extrem, Obere Extremität; AOTT, Acta Orthopaedica et Traumatologica Turcica; JBJS, Journal of Bone and Joint Surgery; BMC Musc Dis, BioMed Central Musculoskeletal Disorders; EJOST, European Journal of Orthopaedic Surgery & Traumatology; WJO, World Journal of Orthopedics; Musc Surg, Musceloskeletal Surgery; AOTS, Archives of Orthopaedic and Trauma Surgery.